Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Surgery Partners, Inc. Director's Dealing 2022

Mar 2, 2022

31430_dirs_2022-03-02_d1cac73b-eae1-4435-834b-0b3bfb064c05.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Surgery Partners, Inc. (SGRY)
CIK: 0001638833
Period of Report: 2022-02-10

Reporting Person: Doherty David T (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-02-25 Common Stock S 2221 $50.48 Disposed 59435 Direct
2022-02-10 Common Stock A 4460 $42.04 Acquired 63895 Direct

Footnotes

F1: Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on February 24, 2022.

F2: Shares issued based on 2021 performance under performance stock unit awards granted to the Reporting Person on March 10, 2021. Shares will vest in two equal annual installments on each of the first two anniversaries of February 10, 2022.